NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $7.1M $15.1M $24.2M $31.5M $36.7M $13.9M $14.3M $9.2M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $7.3M $15.3M $24.4M $31.7M $37.0M $14.5M $14.6M $9.6M
Property, Plant & Equipment $10.8M $11.3M $11.8M $12.0M $5.5M $468.9K $614.8K $802.4K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $374.9K $383.2K $391.5K $399.7K $408.3K $417.0K $425.8K $399.4K
Total Assets $18.5M $27.0M $36.6M $44.2M $43.9M $16.4M $15.6M $10.8M
Liabilities
Accounts Payable $223.3K $135.8K $96.5K $89.5K $376.4K $263.3K $238.4K $79.5K
Total Current Liabilities $881.9K $4.7M $6.7M $600.9K $517.7K $1.2M $1.8M $587.2K
Long-Term Debt $4.7M $4.7M — $0 $5.0M $0 $0 —
Total Liabilities $881.9K $6.7M $13.6M $12.4M $20.5M $8.4M $1.8M $587.2K
Stockholders' Equity
Retained Earnings $-83.7M $-75.1M $-64.8M $-54.1M $-51.9M $38.3M — —
Total Stockholders' Equity $17.7M $20.3M $23.0M $31.8M $23.4M $8.0M $13.9M $10.2M
← Newer Page 2 of 2 Older →